Gefurulimab, sold under the brand name Klygefa, is a medication used for the treatment of myasthenia gravis. It is a bispecific nanobody, targeting complement component 5 (C5) and serum albumin.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.